Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
On May 1, 2025, Eli Lilly and Co (LLY, Financial), a leading pharmaceutical company with a focus on neuroscience, cardiometabolic,
Read MoreOn May 1, 2025, Eli Lilly and Co (LLY, Financial), a leading pharmaceutical company with a focus on neuroscience, cardiometabolic,
Read MoreMarking four decades of innovation, Systech delivers a single platform to CDMOs that eliminates multi-vendor headaches and delivers visibility—from the
Read MoreUnlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.
Read MoreThe mental health epidemic is silent and vast. Brain health diseases are estimated to be responsible for over 13 million deaths,
Read MoreBelgium’s pharmaceutical sector is no longer considered as the most attractive industry to work in. A new study shows how
Read MorePremium The company aims to expand this further through both organic growth and potential acquisitions. (File Image) 3 min read
Read MoreYour support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is
Read MoreTrump meets with retail CEOs to discuss tariffs President Trump recently met with executives from major retailers, including Walmart, Home
Read MoreAn update from ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) is now available. ASKA Pharmaceutical Holdings announced a change
Read MoreTrump has indicated that there may be potential imposition of reciprocal tariffs on pharmaceuticals as well. (AI image) By Hitesh
Read More